Keywords: guilford, sees, progress, across, programs, product, phase

Guilford sees progress across R&D programs

Article | 04 November 1999

Print This

With one product in Phase III clinical trials and several others inPhase I or II development, Guilford Pharmaceuticals might be ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in